Article info
PDFResearch
A prospective study of mifepristone and unlimited dosing of sublingual misoprostol for termination of second-trimester pregnancy in Uzbekistan and Ukraine
- Correspondence to Ingrida Platais, Gynuity Health Projects, New York City, NY 10017, USA; iplatais{at}gynuity.org
Citation
A prospective study of mifepristone and unlimited dosing of sublingual misoprostol for termination of second-trimester pregnancy in Uzbekistan and Ukraine
Publication history
- Received June 20, 2018
- Revised April 16, 2019
- Accepted May 16, 2019
- First published June 4, 2019.
Online issue publication
July 09, 2019
Article Versions
- Previous version (4 June 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.